Biopharmaceutical company focused on developing and commercializing novel vaccines.
2100 Powell Street Suite 900 Emeryville CA 94608, Emeryville, CA · MARGARET MANN
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2023 | DYNAVAX TECHNOLOGIES CORP. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $80,000 | |
| 2023 | DYNAVAX TECHNOLOGIES CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | $80,000 | |
| 2023 | DYNAVAX TECHNOLOGIES CORP. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $120,000 | |
| 2022 | DYNAVAX TECHNOLOGIES CORP. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | $90,000 | |
| 2022 | DYNAVAX TECHNOLOGIES CORP. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | $90,000 | |
| 2022 | DYNAVAX TECHNOLOGIES CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | $90,000 | |
| 2022 | DYNAVAX TECHNOLOGIES CORP. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $120,000 | |
| 2021 | DYNAVAX TECHNOLOGIES CORP. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $50,000 | |
| 2021 | DYNAVAX TECHNOLOGIES CORP. |
4th Quarter (Oct 1 - Dec 31) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORP. | 19 | — |
| Name | Disclosed Prior Position |
|---|---|
| KATHY KULKARNI | Health Policy Legislative Assistant - Office of Congressman Frank Pallone Jr. |